BioSpace News Archive

Bio NC

Disruptive Nutrition and Study Partners Announce First Patient Enrolled in a Clinical Research Study for Nutritional Intervention in Angelman Syndrome

Disruptive Nutrition today announced the first patient enrolled in a clinical research study that it is conducting in collaboration with leading investigators at Monroe Carell Jr. Children’s Hospital at Vanderbilt and the University of South Florida (USF).

January 7, 2019
·
5 min read
Business

Generex Biotechnology CEO Joe Moscato Attending J.P. Morgan Healthcare Conference

J.P. Morgan annual healthcare conference & biotech showcase to be held January 7 – 9 at the Westin St. Francis Hotel, San Francisco, CA

January 7, 2019
·
4 min read
Business

Recursion Announces Options Exercise by Takeda and Extension of AI-enabled Drug Discovery Collaboration

From collaboration to licensing options in less than 18 months

January 7, 2019
·
2 min read
Biotech Beach

Twist Bioscience Enhances Genes Product Offering with Longer Genes and Offers Access to Its Application Programming Interface

In addition, Twist is making its Application Programming Interface available for all customers ordering genes.

January 7, 2019
·
5 min read
Business

PTC Therapeutics Announces Executive Team Updates Focused on Accelerating Pipeline and Bringing Gene Therapy Manufacturing In-house

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the promotion of Dr. Mark Pykett to Chief Scientific Officer and Dr. Neil Almstead to Chief Technical Operations Officer.

January 7, 2019
·
3 min read
Business

Civica Rx Welcomes New Founding Members as 12 Additional Health Systems Join Forces to Reduce Chronic Drug Shortages

Civica Rx has announced that 12 health systems, representing approximately 250 hospitals across the United States, have joined the new not-for-profit generic drug company as founding members.

January 7, 2019
·
2 min read
Pharm Country

IQVIA’s Orchestrated Customer Engagement (OCE) Solution Adopted by More than 30 Life Sciences Companies in First Year of Launch

IQVIA™ (NYSE:IQV) today announced that more than 30 life sciences companies have selected Orchestrated Customer Engagement (OCE) as their commercial solution in the 12 months since the groundbreaking technology first launched

January 7, 2019
·
3 min read
Business

bluebird bio and Inhibrx Announce Collaboration to Research, Develop and Commercialize CAR T Cell Immunotherapies

The small size of sdAbs may enable the generation of more complex CAR T cell products such as those designed to combine additional functions into a single CAR molecule or recognize multiple tumor antigens simultaneously.

January 7, 2019
·
5 min read
Business

Endologix Announces Fourth Quarter and Full-Year 2018 Preliminary Financial Results and Provides 2019 Financial Guidance

Endologix, Inc. (the “Company”) (NASDAQ:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that its preliminary unaudited revenue for the fourth quarter ended December 31, 2018 is expected to be approximately $34 million.

January 7, 2019
·
4 min read
Business

Clovis Oncology Announces Product Revenues for the Fourth Quarter and Full Year 2018

Clovis Oncology, Inc. (NASDAQ:CLVS) today announced its preliminary, unaudited revenues for the fourth quarter and full year ended December 31, 2018.

January 7, 2019
·
5 min read